Vivos Inc (RDGL)

[SC8]

From RDGL Blog:

From March 2023 update:
“Phase One testing has been completed.”

From April 2023 update:
“The Phase Two 100Gy injections were completed. The focus was on treating margins of a complex tumor morphology tumor shape for future publications. Next month the 400 Gy injections will be administered. CT imaging of tumor volume is being measured over time to track effectiveness. Histopathology analysis is also ongoing. The final report is being outlined for the Phase One portion for submission to the FDA.”